Key result
Nitric oxide regulates cardiovascular haemodynamics and pathology through interactions forming peroxynitrite, S-nitrosothiols, and non-haem iron-dinitrosyl dithiolate complexes.
This review highlights the complex biochemical interactions of nitric oxide in the cardiovascular system, identifying potential novel pharmacological targets for future therapies.
NO interactions may reveal novel targets; leaves open clinical validation in cardiovascular disease.
In the cardiovascular system, nitric oxide (NO) is involved in the short and long-term regulation of haemodynamics, and in a number of their pathological alterations. Investigation into the biochemistry of NO-synthase isoforms has confirmed that they also all produce superoxide anion (O(*)). The free radical NO can interact with many targets on which novel information has been recently obtained. The major results of these interactions are not only the well known activation of guanylyl cyclase, but also the formation of potentially cytotoxic peroxynitrite (ONOO(-)), and the formation of S-nitrosothiols and non-haem iron-dinitrosyl dithiolate complexes. Tissue O(2), O(*), low molecular weight thiols and transition metals (especially FeII) play a pivotal role in directing NO towards targets responsible for biological effects, or storage or release from these stores. In addition, circulating forms of NO have been proposed with S-nitrosation of blood proteins. All these mechanisms provide potential pharmacological targets for future therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Stoclet et al. (1998) conducted a review in Cardiovascular system physiology and pathology. Nitric oxide was evaluated. Nitric oxide regulates cardiovascular haemodynamics and pathology through interactions forming peroxynitrite, S-nitrosothiols, and non-haem iron-dinitrosyl dithiolate complexes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: